Related Experiment Video
Updated: Feb 4, 2026
14:56
The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb
Published on: September 23, 2018
9.5K
Optimizing Antibiotic Drug Therapy in Pediatrics: Current State and Future Needs.
Jennifer Le1, John S Bradley2,3
1Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California at San Diego, La Jolla, CA, USA.
Journal of Clinical Pharmacology
|September 25, 2018
Summary
Optimizing pediatric antibiotic dosing requires understanding how age and body size affect drug levels for better treatment. Clinical pharmacometrics and specialized study designs help tailor antibiotic therapy for children.
Area of Science:
- Pediatric Pharmacology
- Clinical Pharmacy
- Antibiotic Stewardship
Background:
- Antibiotic selection and dosing in children are complex due to significant pharmacokinetic variability related to age and physiological maturation.
- Optimizing drug exposure is crucial for achieving clinical response and preventing resistance in pediatric patients.
- Pediatric populations span diverse age groups, from neonates to adolescents, each with unique physiological characteristics influencing drug disposition.
Purpose of the Study:
- To review and evaluate recent literature on optimizing antibiotic pharmacotherapy in pediatric populations.
- To highlight the importance of pharmacokinetic variability and pharmacodynamics in pediatric antibiotic dosing.
- To discuss quantitative approaches and practical strategies for successful pediatric antibiotic studies.
Main Methods:
- Systematic review of literature published within the last decade concerning pediatric antibiotic pharmacotherapy.
- Critical evaluation of specific pediatric antibiotic data, including beta-lactams, aminoglycosides, and vancomycin.
- Analysis of clinical pharmacometric approaches, such as population pharmacokinetic modeling, Bayesian estimation, and Monte Carlo simulations.
Main Results:
- Age-related physiological maturation significantly impacts pharmacokinetic variability in pediatric patients.
- Body size and age are critical factors for optimizing antibiotic dosing in children.
- Clinical pharmacometrics provide a quantitative framework for predicting antibiotic efficacy and individualizing treatment.
Conclusions:
- Individualized antibiotic dosing in pediatric patients is essential for optimizing therapeutic outcomes.
- Understanding pharmacokinetic variability and employing advanced modeling techniques are key to effective pediatric antibiotic therapy.
- Practical study designs and sampling strategies facilitate robust research in pediatric pharmacology.
Keywords:
Bayesian methodsMonte Carlo simulationPharmacokineticaminoglycosidesantibioticsantimicrobialsbeta-lactamsceftarolineneonatesopportunistic studypediatricspharmacodynamicvancomycinMore Related Videos
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
13.5K
10:50Design and Use of a Low Cost, Automated Morbidostat for Adaptive Evolution of Bacteria Under Antibiotic Drug Selection
Published on: September 27, 2016
10.2K
Related Concept Videos
01:28Drug Therapy
298
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
298
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
264
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
264
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
311
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
311
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
233
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
233
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
301
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
301
00:57Antibiotic Selection
60.0K
Overview
60.0K